ACTIVE

APOTHEEK BOSEIND

Financial year 2025 · Closed on 31/12/2025

Net result265,8 k €-1,6 %over 1 year
Gross margin513,3 k €+3,4 %over 1 year
Equity320,8 k €+0,0 %over 1 year
Workforce2,4 ETP+26,3 %over 1 year

Identity

Source · BCE/KBO

APOTHEEK BOSEIND is a Public limited company incorporated in 2003. Its main activity is: Dispensing chemist in specialised stores. Its registered office is in Pelt. It employs on average 2,4 ETP workers (FTE).

Legal situation
Normal situation
BCE/KBO no. / VAT
BE 0479.593.140
Incorporation
19/02/2003
Legal form
Public limited company
Registered office
Boseind 18
3910 Pelt · FlandreSee on map
Contributed capital
62 000,00 €
Latest accounts
31/12/2025
Average workforce
2,4 ETP
Joint committees (1)
  • 313
Signals
ProfitableLow riskGood liquidityPositive cashflowPositive EBITDAHealthy social debts

Financials

Source · NBB, 20 filings

Trend over 20 financial years

20252024202320222021
Income statement
Gross margin513,3 k €496,6 k €377,6 k €299,1 k €326,1 k €
EBITDA388,4 k €382,9 k €270,2 k €197,2 k €258,8 k €
Operating result330,3 k €324,7 k €212,2 k €174,9 k €247,8 k €
Net result265,8 k €270,1 k €194,1 k €206,9 k €245,7 k €
Balance sheet
Equity320,8 k €320,8 k €320,8 k €320,7 k €186,8 k €
Total assets1,3 M €1,1 M €1,1 M €1,6 M €903,9 k €
Cash405,5 k €256,5 k €247,1 k €505,1 k €396 k €
Debts961,3 k €828 k €821,3 k €1 M €692,6 k €
Other
Workforce2,4 ETP1,9 ETP2,1 ETP2,3 ETP1,5 ETP

Valuation

Indicative valuation

As an indication, this company is worth

between 1 M€ and 2,5 M€
See the valuation

Board of directors

Source · NBB, accounts to 31/12/2025

1 active · 3 ended

Active mandates

DirectorMandates in this companyPeriod
B & V PHARMA0877.584.833Represented by Bart HELEVEN
Directorsince 19/10/2022Managing director01/01/2018 → 2020 accountsended

Ended mandates

DirectorMandates in this companyPeriod
Marcel Heleven
Director01/01/2018 → 2020 accounts
B&V B&V PHARMA BVBA
Managing director2014 accounts
BVBA B&V PHARMA
Managing director2015 accounts

Full financial information

Source · NBB
202520242023202220212020
Type of accountAbridged modelAbridged modelAbridged modelAbridged modelAbridged modelAbridged model
Start of the financial year01/01/202501/01/202401/01/202301/01/202201/01/202101/01/2020
Closing of the financial year31/12/202531/12/202431/12/202331/12/202231/12/202131/12/2020
Length of the financial year12 months12 months12 months12 months12 months12 months
Filing date18/06/202610/06/202529/08/202416/08/202331/08/202227/08/2021
General meeting23/05/202624/05/202525/05/202427/05/202328/05/202222/05/2021
Currency of the financial yearEUREUREUREUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for free

Annual accounts filings

Source · NBB, 20 filings
ModelClosingGeneral meetingFiledLanguageDocument
Abridged model31/12/202523/05/202618/06/2026DutchPDF
Abridged model31/12/202424/05/202510/06/2025DutchPDF
Abridged model31/12/202325/05/202429/08/2024DutchPDF
Abridged model31/12/202227/05/202316/08/2023DutchPDF
Abridged model31/12/202128/05/202231/08/2022DutchPDF
Abridged model31/12/202022/05/202127/08/2021DutchPDF
Abridged model31/12/201923/05/202007/07/2020DutchPDF
Abridged model31/12/201829/06/201920/08/2019DutchPDF
Abridged model31/12/201730/06/201805/07/2018DutchPDF
Abridged model31/12/201630/06/201722/08/2017DutchPDF
Abridged model31/12/201528/05/201622/06/2016DutchPDF
Abridged model31/12/201423/05/201529/06/2015DutchPDF
Abridged model31/12/201324/05/201412/06/2014DutchPDF
Abridged model31/12/201225/05/201315/06/2013DutchPDF
Abridged model31/12/201126/05/201216/06/2012DutchPDF
Abridged model31/12/201028/05/201108/06/2011DutchPDF
Abridged model31/12/200922/05/201029/05/2010DutchPDF
Abridged model31/12/200823/05/200906/06/2009DutchPDF
Abridged model31/12/200723/05/200829/05/2008DutchPDF
Abridged model31/12/200626/05/200701/06/2007DutchPDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 1 M€ and 2,5 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2025

1 active · 3 ended

Active mandates

DirectorMandates in this companyPeriod
B & V PHARMA0877.584.833Represented by Bart HELEVEN
Directorsince 19/10/2022Managing director01/01/2018 → 2020 accountsended

Ended mandates

DirectorMandates in this companyPeriod
Marcel Heleven
Director01/01/2018 → 2020 accounts
B&V B&V PHARMA BVBA
Managing director2014 accounts
BVBA B&V PHARMA
Managing director2015 accounts

Ownership and network

Looking for more information about this company?

Try for free

Belgian Official Gazette publications

Source · Belgian Official Gazette
  • Mandates26/01/2023
    STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, …) - BENAMING - ONTSLAGEN - BENOEMINGEN
    PDF
  • Mandates14/09/2018
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Mandates08/06/2012
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Mandates24/04/2006
    ONTSLAGEN - BENOEMINGEN - ALGEMENE VERGADERING - KAPITAAL - AANDELEN - STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, …)
    PDF
  • Mandates07/03/2006
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Mandates23/10/2003
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Other27/02/2003
    RUBRIEK OPRICHTING (NIEUWE RECHTSPERSOON, OPENING BIJKANTOOR, ENZ...)
    PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

Source · CBE, NBB annual accounts
Year
Identity
Incorporation
Name
Registered office
Annual accounts
Filings20 filings
Mandates
B & V PHARMA
Marcel Heleven
B&V B&V PHARMA BVBA
BVBA B&V PHARMA
200320042005200620072008200920102011201220132014201520162017201820192020202120222023202420252026
APOTHEEK BOSEINDApotheek Van Moll
Boseind 18, 3910 Neerpelt
DirectorManaging director
Director
CurrentPlanned, not yet servedEndedAccounts filedToday

Registered offices

Source · NBB annual accounts, CBE
Registered addressPeriodSource
Boseind 18, 3910 NeerpeltCurrent
accounts 2022 → 2025
Accounts 2025 · 2026-00173108
Boseind 18, 3900 Pelt
accounts 2021
Accounts 2021 · 2022-20391395

Company names

Source · NBB annual accounts, CBE
NamePeriodSource
APOTHEEK BOSEINDCurrent
accounts 2022 → 2025
Accounts 2025 · 2026-00173108
Apotheek Van Moll
accounts 2006 → 2021
Accounts 2021 · 2022-20391395

Events

  1. 2025
    Annual accounts 2025265,8 k €↓
  2. 2024
    Annual accounts 2024270,1 k €↑
  3. 2023
    Annual accounts 2023194,1 k €↓
  4. 2022
    Annual accounts 2022206,9 k €↓
  5. 2022
    Name changeAPOTHEEK BOSEIND
  6. 2021
    Annual accounts 2021245,7 k €↑
  7. 2020
    Annual accounts 2020235,4 k €↓
  8. 2019
    Annual accounts 2019243,8 k €↑
  9. 2018
    Annual accounts 2018193,8 k €↑
  10. 2017
    Annual accounts 2017182,6 k €↓
  11. 2016
    Annual accounts 2016193,9 k €↑
  12. 2015
    Annual accounts 2015188,8 k €↑
  13. 2014
    Annual accounts 2014151,6 k €↓
  14. 2013
    Annual accounts 2013163,2 k €↑
  15. 2012
    Annual accounts 201278,2 k €↑
  16. 2011
    Annual accounts 201168,6 k €↑
  17. 2010
    Annual accounts 201042,1 k €↓
  18. 2009
    Annual accounts 200942,7 k €↓
  19. 2008
    Annual accounts 200886,9 k €↑
  20. 2007
    Annual accounts 200739,5 k €↑
  21. 2006
    Annual accounts 200635,3 k €
  22. 19/02/2003
    IncorporationPublic limited company